Breaking News

Plasticell, JCR Pharma Enter Cell Technology Pact

To deploy CombiCult in Japan

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Plasticell has signed a collaboration agreement with JCR Pharmaceuticals Co., Ltd. of Ashiya, Japan, to discover custom stem cell culture media using its combinatorial stem cell technology, CombiCult. Plasticell will work with JCR scientists to deploy CombiCult to discover GMP-ready protocols for therapeutic applications. Financial terms were not disclosed.   “Plasticell’s core capability to provide customers with optimized serum- and xeno-free GMP-grade stem cell differentiation or expansion pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters